Capabilities

Healthcare IT and Digital Health Overview

Healthcare IT and Digital Health Overview

Three key lessons for digital health investors from the demise of Babylon Health

News

Three key lessons for digital health investors from the demise of Babylon Health

When Babylon Health listed in New York in 2021, the telehealth company was valued at $4.2bn. Within a year later the stock price collapsed and it later filed for bankruptcy. The company’s British assets sold for only £500k. We look at three key lessons for digital health investors.

27 August 2025
•
babylon , blitzscaling , digital health , Health & Care ...

Capabilities

Healthcare Services Overview

Healthcare Services Overview
Behavioural and Mental Health

Behavioural and Mental Health

The most outsourced of all clinical specialties
Children's Services and Education

Children's Services and Education

Operators of special educational needs schools, alternative provision, and education services for children requiring additional support
Care Homes

Care Homes
Clinical Homecare

Clinical Homecare

Specialist providers administering high-acuity treatments such as infusions, biologics and oncology therapies in the home setting
Clinical Laboratories

Clinical Laboratories

Laboratory networks and pathology operators delivering diagnostic testing to hospitals, clinics, and consumers
General Hospitals

General Hospitals

Clear strategy on portfolios, pathways and payors
Specialist Hospitals & Clinics

Specialist Hospitals & Clinics

Operators of acute hospitals, day-surgery and outpatient facilities including opthalmic, imaging centres, cancer and radiotherapy clinics, and ambulance services
Workforce & Support Services

Workforce & Support Services

Staffing agencies, locum platforms and other service providers supplying clinicians and other essential support functions

Market opportunities for surgical ophthalmic equipment and products

News

Market opportunities for surgical ophthalmic equipment and products

Johan Ottosson, Senior Associate and Dr. Victor Chua, Senior Partner see significant opportunities in the market for surgical ophthalmic equipment and products

20 August 2025
•
Health Systems & Data

Capabilities

Health Systems & Payors Overview

Health Systems & Payors Overview
NHS

NHS

Public health systems including NHS Trusts, Integrated Care Boards and Local Authorities
Commissioning & System Design

Commissioning & System Design

Authorities and commissioning bodies shaping financial models and system architecture, including NICE and national commissioners here in the UK
Private Health Insurers

Private Health Insurers

Managed care organisations, health insurers and payors financing and reimbursing healthcare

The Hardware of Healthcare

News

The Hardware of Healthcare

Johan Ottosson, Senior Associate and Dr. Victor Chua, Senior Partner see significant opportunities in the market for surgical ophthalmic equipment and products

20 August 2025
•
Health Systems & Data

Capabilities

Pharma Overview

Pharma Overview
Consumer Health

Consumer Health

Providers of dentistry, optical, audiology, fertility, pharmacy, and wellness services, including fast-growing retail and patient-pay segments
Innovative Pharma

Innovative Pharma

The large originator companies that invest heavily in R&D and drive global therapeutic innovation
Biotech

Biotech

Emerging and mid-cap biopharma firms, often venture-backed and focused on advancing new platforms and modalities
Generic Pharma

Generic Pharma

Generics, biosimilars and specialty pharma companies focus on cost-competitive supply or niche formulation and complex / hospital-only medicines.
Radiopharma

Radiopharma
Speciality Pharma

Speciality Pharma
Pharma Services (SMOs/CROs)

Pharma Services (SMOs/CROs)

Contract research organisations and site management organisations deliver outsourced trial execution and patient recruitment.
Pharma Manufacturing Services (CDMOs)

Pharma Manufacturing Services (CDMOs)

CDMOs support pharma & biotech with process development, scale-up and contract manufacturing.

Radiopharmaceuticals - where hot molecules meet cold capital

Radiopharmaceuticals - where hot molecules meet cold capital

Radiopharmaceuticals remains a hot topic in 2026, with continued investment from both big and mid-sized pharma, and private equity in the last twelve months. Will Johnson, engagement manager, Lakshiv Dhingra, clinical fellow, and Victor Chua, Partner, at Mansfield Advisors outline key developments and potential asset classes for private equity investors considering the sector.

Capabilities

Life Sciences Overview

Life Sciences Overview
Advanced Modalities & Therapies

Advanced Modalities & Therapies

Developers of next-generation approaches such as cell and gene therapies, oligonucleotide and RNA technologies, genomics & proteomics
Lab Equipment & Consumables

Lab Equipment & Consumables

Companies supplying laboratory instruments, benchtop equipment, single-use technologies and consumables
Research Tools & Technologies

Research Tools & Technologies

Providers of reagents, assays, bioinformatics platforms, and discovery systems

Capabilities

Med Tech Overview

Med Tech Overview
Devices & Implants

Devices & Implants

Manufacturers of high-tech medical devices such as cardiac implants, orthopaedics, neuromodulation systems, stents and wound-care products
Diagnostics & Monitoring

Diagnostics & Monitoring

Firms in imaging, in-vitro diagnostics, digital monitoring and point-of-care testing
Equipment & Consumables

Equipment & Consumables

Suppliers of surgical tools, hospital equipment and single-use products

Investing in non-therapeutic antibodies

Investing in non-therapeutic antibodies

Johan Ottosson, Senior Associate and Dr. Victor Chua, Senior Partner see significant opportunities in the market for surgical ophthalmic equipment and products

Capabilities

Veterinary & Animal Health Overview

Veterinary & Animal Health Overview
Veterinary Services

Veterinary Services

Veterinary clinic groups, hospitals and diagnostic providers serving companion animals and pets
Animal Pharma

Animal Pharma

Companies producing medicines, vaccines, and feed additives that improve health and productivity across pets and livestock

Pet Food 2036: Growth and Disruption in Cat and Dog Food

Pet Food 2036: Growth and Disruption in Cat and Dog Food

Capabilities

Market Mapping and Sizing

Market Mapping and Sizing

Shows where opportunities exist and their scale, through structured market analysis.
Country Entry

Country Entry

Guides entry into new geographies, supported by risk–benefit assessment and route-to-market planning.
Strategic Marketing

Strategic Marketing

Strengthens how you reach and engage customers, drawing on segmentation and positioning tools.
Competitive Positioning

Competitive Positioning

Clarifies how to stand out and defend share, using competitor benchmarking and strategy frameworks.

Capabilities

Revenue Quality Assessment

Revenue Quality Assessment

Examines the durability of income, using customer, contract, and market analysis.
Revenue at Risk

Revenue at Risk

Examines the durability of income, using customer, contract, and market analysis.
Market Opportunity Assessment

Market Opportunity Assessment

Identifies and quantifies growth potential, supported by market sizing and forecast models.
Pricing Validation

Pricing Validation

Tests how sustainable current prices are, informed by customer feedback and market evidence.
Health Technology Assessment

Health Technology Assessment

Evaluates adoption potential and reimbursement prospects through structured evidence review.

Capabilities

Competitive Analysis

Competitive Analysis

Compares strengths and weaknesses against peers, using structured benchmarking.
Value Creation Advisory

Value Creation Advisory

Pinpoints the actions that drive growth and efficiency, aligned to investor and board priorities.
Underperformance Diagnostics

Underperformance Diagnostics

Identifies the real causes of missed targets, using root-cause and capability analysis.
Multi-Business Portfolio Review

Multi-Business Portfolio Review

Tests whether the portfolio is strategically coherent, supported by capital allocation and fit analysis.

Local Market Benchmarking

Local Market Benchmarking

Measures how performance compares locally, using peer benchmarks and market data.
Market-Model Fit Assessment

Market-Model Fit Assessment

Examines how well the business model matches market dynamics, using practical fit-for-purpose tests.
Board-Level Performance Narratives

Board-Level Performance Narratives

Develops clear, evidence-based stories for governance and stakeholder communication.
Repositioning Recommendations

Repositioning Recommendations

Defines how to reset direction, based on market trends and competitive realities.

Capabilities

Go-To-Market

Go-To-Market

Lays out the path to customers, informed by adoption patterns and channel economics.
Pricing and Reimbursement

Pricing and Reimbursement

Builds approaches that balance payer, provider, and patient value, grounded in reimbursement rules.
Public-Private Partnerships

Public-Private Partnerships

Shapes collaborations that expand access, supported by practical partnership structures.
Organisation Design

Organisation Design

Aligns teams and structures with strategy, using operating-model and governance design.

Capabilities

Digital Maturity Assessment

Digital Maturity Assessment

Gauges readiness for change, using staged capability assessments.
Value-Based Care Digital Enablement

Value-Based Care Digital Enablement

Builds digital enablers for outcomes-based health, guided by value-based care frameworks.
Health Strategy and Systems Design

Health Strategy and Systems Design

Designs digitally enabled health systems, informed by system-level commissioning models.
Digital Integration

Digital Integration

Connects platforms and data, supported by interoperability and system architecture.
Digital Investment Strategy and Prioritisation

Digital Investment Strategy and Prioritisation

Directs capital to the initiatives with the greatest impact, using portfolio prioritisation tools.

Insights

Insights
Therapeutic Products and Innovation

Therapeutic Products and Innovation
Health & Care

Health & Care
Health Systems & Data

Health Systems & Data

Animal Health

Animal Health
Investment

Investment
Webinars

Webinars

About Us

About Us

Our People

Our People

A pharmaceutical manufacturing machine fills glass vials with clear liquid on a curved conveyor belt, with metal filling nozzles positioned above the red-capped bottles in a sterile production facility.

Creating value in Healthcare and Life Sciences

We work for public and private companies and investors, helping them understand the key commercial questions when growing, buying and selling businesses

A woman in casual clothing sits at a wooden table near a window, working on a laptop computer with potted plants visible in the bright, naturally-lit room.

Sector

Healthcare

A workspace showing red cylindrical containers, white bottles, and scattered papers on a desk, suggesting a laboratory or research environment with various supplies and documentation.

Sector

Life Sciences

a close up image of part of the process in pharma and life sciences manufacturing machinery

Sector

Pharma

Mansfield is a leading healthcare and life sciences strategy consulting firm as ranked by the Financial Times and Vault

We advise on corporate strategy, value creation and commercial due diligence by combining research, modelling and analysis with clinical, scientific and operational knowledge

Selected Clients and Assets we have worked on

Our Latest Insights

Expert analysis across healthcare, life sciences, pharma, social care and digital

Specialty Pharma Opportunities for PE Funds

Speciality Pharma Opportunity Assessment

Therapeutic Products and Innovation

A human hand and robotic hand reach toward each other against a blue technological background, with the human hand displaying healthcare symbols including a medical cross, while the robot hand shows

A Healthcare Investor’s Guide to “AI Exposure”

Investment

A white pet food bowl containing brown kibble sits on a wooden floor, with a person's hand visible in the background holding what appears to be a leash.

Pet Food 2036: Growth and Disruption in Cat and Dog Food

Animal Health

A blister pack of white round pills or tablets against a bright red-orange gradient background.

Radiopharmaceuticals – where hot molecules meet cold capital

Therapeutic Products and Innovation

A red label reading

GLP-1 2.0: Where the next wave of value will be created

Therapeutic Products and Innovation

A woman with blonde hair wearing a white t-shirt holds her hands together in a prayer or meditation pose, with pink nail polish visible and a smartwatch on her wrist.

Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority

Health & Care

A white ambulance with red cross and blue medical symbols is parked in front of a modern medical facility, with traditional Mediterranean-style buildings and cypress trees visible on the hillside in the background.

Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in

Investment

A green-painted Village GP Practice storefront with large windows and a medical cross sign, located in a traditional British brick building on a paved street.

Will primary care always be secondary for investors?

Health & Care

Three key lessons for digital health investors from the demise of Babylon Health

Health & Care

A minimalist office workspace showing a cork board with two data visualization charts (bar chart and line graph) clipped with blue binder clips, alongside an hourglass icon on the wall and a desk surface with a clipboard and stack of folders.

A Quick Update on NHS Waiting Lists

Health & Care

News & Insights

Healthcare news, data and analysis

Via Investors in Healthcare

Switzerland: Memo Therapeutics to be acquired by Ipsen for a total potential consideration exceeding €700m

1 July 2026

Life Sciences ,

M&A ,

News ,

Adjuvant Capital ,

Andreas Rötheli

UK: Klick Health acquires Oxford PharmaGenesis

1 July 2026

M&A ,

News ,

Pharma ,

Services – Bioinformatics ,

Alex Weatherall

UK: Caidya announces strategic combination with Simbec-Orion

1 July 2026

M&A ,

News ,

Pharma ,

Services – CRO/CMO/CDMO ,

Adam Richardson

Germany/Netherlands: TPG launches Arcura Medical Properties following acquisition of German and Dutch medical outpatient portfolio

1 July 2026

Healthcare ,

Hospitals and Clinics ,

News ,

People ,

Real Assets

France: Destia accelerates next phase of growth with new investors

1 July 2026

Homecare ,

News ,

Social Care ,

Agilys Avocats ,

Albane Eglinger

UK: Mansfield Advisors announces two internal promotions

30 June 2026

Healthcare ,

Life Sciences ,

News ,

People ,

Filippos Papadopoulos

Switzerland: Impact Healthcare completes its portfolio in integrated care with acquisition of Gimv’s majority stake in AlpenBlu Clinics

30 June 2026

Buy Out ,

Healthcare ,

M&A ,

Mental Health ,

News

Italy: G Square acquires majority shareholding in Valtecne with view to delisting

30 June 2026

Buy Out ,

Life Sciences ,

M&A ,

Medtech – Hospital Equipment ,

Medtech – Medical Devices and Implants

Belgium: Aedfica signs first syndicated sustainability-linked RCF as Europe’s largest listed healthcare REIT

30 June 2026

Care Homes ,

Debt ,

News ,

Real Assets ,

Social Care

Norway: Unident acquires Dental Miljø Teknikk

30 June 2026

Dental ,

Healthcare ,

M&A ,

News ,

Dental Miljø Teknikk

Croatia: Advance Capital Partners to acquire 50% Stake in Adria Dental Group from Provectus Capital Partners

30 June 2026

Buy Out ,

Dental ,

Healthcare ,

M&A ,

News

UK: RQ Bio raises US$115m Series A to advance long-acting antibody programme for full season influenza prevention

29 June 2026

Life Sciences ,

News ,

Venture ,

EQT Life Sciences ,

Forbion

France: padoa announces growth investment from Thoma Bravo alongside co-founders and existing shareholders, Five Arrows and Kamet Ventures

29 June 2026

Digital Health/Healthtech ,

Healthcare ,

News ,

Venture ,

Cédric Mathorel

UK: HB Fuller seals acquisition of AMS for £715m

29 June 2026

Life Sciences ,

M&A ,

Medtech – Hospital Equipment ,

Medtech – Medical Devices and Implants ,

News

Germany: Orifarm sharpens focus on pharmaceuticals with divestment of VMS portfolio to Stada

29 June 2026

Buy Out ,

Consumer Healthcare ,

Healthcare ,

M&A ,

Manufacturing – Generics

Nordics: Northern Horizon completes €130m of acquisitions in social infrastructure assets

29 June 2026

Care Homes ,

M&A ,

M&A Deals ,

News ,

Real Assets

Spain: Metric Capital leads investment in Dental Company

29 June 2026

Buy Out ,

Dental ,

Healthcare ,

M&A ,

News

Switzerland: SOPHiA Genetics raises US$57.5m to fund next phase of growth

22 June 2026

Life Sciences ,

Medtech – Healthcare IT ,

News ,

Public Equity ,

BTIG

Switzerland: Decalia Capital and founding shareholders sell MediGroup to ImaOne

22 June 2026

Buy Out ,

Diagnostics ,

Healthcare ,

Life Sciences ,

M&A

UK: Iain Lock joins Cluttons as head of Healthcare & Senior Living division

22 June 2026

Care Homes ,

News ,

People ,

Real Assets ,

Social Care

Germany: DHCare taking next step in European mobility solutions with agreement to carve out Ottobock’s Human Mobility division

19 June 2026

Buy Out ,

Life Sciences ,

M&A ,

Medtech – Medical Devices and Implants ,

News

GCC: Amanat Holdings completes 100% acquisition of Cambridge Health Group

19 June 2026

Healthcare ,

Hospitals and Clinics ,

M&A ,

News ,

Ali Saeed bin Harmal Aldhaheri

Europe: Sander Slootweg named chair of Invest Europe

18 June 2026

Life Sciences ,

News ,

People ,

Venture ,

BioGeneration Ventures (BGV)

US: CVC Catalyst to acquire majority stake in WillowWood from Blue Sea Capital, the Arbogast family and management

18 June 2026

Buy Out ,

Life Sciences ,

M&A ,

Medtech – Medical Devices and Implants ,

News

Spain: Burcu Ozturk joins IVI RMA as chief financial and integration officer

18 June 2026

Fertility ,

Healthcare ,

News ,

People ,

Burcu Ozturk